PAT8 presented p.G12D-mutated KRAS in primary tumor and wild-type KRAS in the liver metastasis; nevertheless, he presented neither a specific pattern nor a relevant cytotoxic activity against tumor target cells, with degranulation rates ranging from 5% to 10% for both NK and T cells. The gene discussed is KRAS; the disease is neoplasm.